This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: National Institute of Health and Medical Research, Novartis Ag. Active years: 2016.
Company Filing History:
1 out of 1,853 
1 out of 3,973 
Years Active: 2016
Title: Thirry Léveillard: Innovator in Ocular Disorder Diagnosis
Introduction
Thirry Léveillard is a notable inventor based in Maisons-Alfort, France. He has made significant contributions to the field of ocular disorders through his innovative research and patented inventions. His work focuses on the early diagnosis, monitoring, and treatment of various ocular conditions.
Latest Patents
Thirry Léveillard holds a patent related to disease-associated proteins. This patent discloses methods and compositions for the early diagnosis, monitoring, and treatment of ocular disorders. In particular, the invention pertains to a novel protein that is differentially transcribed and expressed in subjects suffering from retinal dystrophies, such as retinal dystrophy and age-related macular degeneration, compared to healthy subjects. The patent also includes antibodies that recognize this protein and methods for diagnosing such conditions. He has 1 patent to his name.
Career Highlights
Throughout his career, Thirry Léveillard has worked with prominent organizations, including Novartis AG and the National Institute of Health and Medical Research. His experience in these institutions has allowed him to advance his research and contribute to the scientific community significantly.
Collaborations
Thirry Léveillard has collaborated with esteemed colleagues, including Jose-Alain Sahel and Olivier Poch. These partnerships have further enriched his research and innovation in the field of ocular health.
Conclusion
Thirry Léveillard is a distinguished inventor whose work has the potential to transform the diagnosis and treatment of ocular disorders. His innovative approaches and collaborations highlight the importance of research in improving patient outcomes.